Sharemaestro Newsreel

Diluted shares outstanding of Bionano Genomics, Inc. – GETTEX:2Y3

This article provides financial information for Bionano Genomics, Inc. (GETTEX:2Y3), specifically focusing on its diluted shares outstanding. The content is presented within the TradingView platform, offering various financial data points and tools for analysis.

BAXTER INTERNATIONAL INC. : WELLS FARGO RAISES TARGET PRICE TO $23 FROM $19

Wells Fargo has increased its target price for Baxter International Inc. (BAX.N) shares to $23 from the previous $19. This adjustment reflects an updated outlook from the financial institution regarding the medical products company. The information is sourced from Reuters.

RBC Capital Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating, Maintains Target Price $21

RBC Capital has reiterated its Buy rating for Bausch + Lomb Corp. (BLCO.US) and maintained its target price at $21. This indicates continued confidence in the company's performance and future outlook from the investment bank.

Net income before discontinued operations of Bionano Genomics, Inc. – GETTEX:2Y3

This page provides financial data, specifically net income before discontinued operations, for Bionano Genomics, Inc. (2Y3) listed on Gettex. The content is primarily a data placeholder within TradingView's platform, indicating no trades have occurred for this particular metric yet.

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Average Rating of "Moderate Buy" by Brokerages

LeMaitre Vascular, Inc. (NASDAQ:LMAT) has received an average "Moderate Buy" rating from brokerages, with an average 12-month price target of $112.60. The company recently surpassed quarterly EPS expectations and saw an 11.1% revenue increase. Despite insider stock sales totaling approximately $5.9 million, institutional investors …

Repligen Corp (RGEN) Institutional Confidence

Repligen Corp (RGEN) has an institutional confidence score of 10.00, placing it first in its industry. Institutional shareholding increased by 3.23% quarter-over-quarter, with Lee Ainslie being the largest shareholder. The article lists the top institutional shareholders and their recent activity.

Avantor, Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:AVTR) 2026-07-31

Avantor, Inc. published its Q2 2026 earnings call presentation on July 31, 2026. The company reported an EPS of $0.21, beating estimates by $0.02, and revenue of $1.69 billion, a 0.53% year-over-year increase, beating estimates by $84.65 million. This article provides access to the …

Price to book forward of DENTSPLY SIRONA, Inc. – BX:DY2

This article provides financial data for DENTSPLY SIRONA, Inc. (BX:DY2), specifically its price-to-book forward ratio. It indicates that the market is closed for this stock and no trades have occurred. The content is primarily a data point with no further analysis or discussion.

BioLife Solutions, Inc. Revenue Breakdown – NASDAQ:BLFS

This article provides a revenue breakdown for BioLife Solutions, Inc. (NASDAQ: BLFS). Last year, the company generated $96.21 million USD, with its top-performing segment, Bioproduction Products and Services, contributing the entire amount. The United States was the primary revenue source, accounting for $76.97 million …

Sanara MedTech (NASDAQ:SMTI) Downgraded by Wall Street Zen to Buy

Nyxoah (NASDAQ:NYXH) Stock Rating Upgraded by Wall Street Zen

The Manufacturers Life Insurance Company Purchases 148,703 Shares of Merit Medical Systems, Inc. $MMSI

Merit Medical (MMSI) Stock Eyes Bigger Growth Run After Profit Outlook Lift

Nephros Inc (NEPH) Financial Health: Profitability & Balance Sheet Analysis

The article provides an analysis of Nephros Inc's (NEPH) financial health, noting its current financial score of 6.42, ranking 125 out of 159 in its industry. The company's financial status is described as robust, with low operating efficiency, and it recently reported a 6.87% …

OraSure Technologies, Inc. Revenue Breakdown – NASDAQ:OSUR

OraSure Technologies, Inc. (NASDAQ: OSUR) reported total revenue of $115.02 million USD last year. The Human Immunodeficiency Virus segment was its top performer, generating $49.80 million USD, though this was a decrease from $60.80 million USD in the prior year. The United States was …

Enterprise value to EBITDA forward of Pulse Biosciences, Inc – NASDAQ:PLSE

This article provides the enterprise value to EBITDA forward for Pulse Biosciences, Inc. (NASDAQ: PLSE). It also lists the company's trading information on the Nasdaq Stock Market and provides links to its financials, documents, news, and other market data.

Embecta Corp. Revenue Breakdown – NASDAQ:EMBC

Pulse Biosciences (PLSE) Passes AF Study Milestone As Investors Weigh An Overvalued Narrative

Pulse Biosciences (PLSE) has reached a significant milestone in its NANOPULSE-AF Study, with its nPulse System for atrial fibrillation quickly passing the enrollment midpoint. This clinical progress has fueled a strong rally in its share price, with substantial returns over the last 7, 90 …

MERIT MEDICAL SYSTEMS INC : NEEDHAM RAISES TARGET PRICE TO $101 FROM $90

Needham has increased its target price for Merit Medical Systems Inc (MMSI.O) from $90 to $101. This update reflects a positive revision in the analyst's outlook for the company. The news was reported by Reuters.

Kestra Medical (KMTS) executive files Rule 144 notice for potential stock sale

Vaseem Mahboob, an executive at Kestra Medical Technologies, Ltd. (KMTS), has filed a Rule 144 notice to sell common stock through Merrill Lynch on or after July 31, 2026. These shares were acquired via the vesting of performance share unit awards on July 17, …

West Pharmaceutical Services (WST) Raised Guidance, Is It Still 16% Undervalued?

West Pharmaceutical Services (WST) has seen renewed investor interest after reporting strong Q2 2026 results, raising its full-year revenue outlook, and continuing share buybacks and dividends. While a narrative suggests the stock is 16% undervalued with a fair value of $404, its current P/E …

AngioDynamics (ANGO) SVP Warren Nighan Sells 23,370 Shares

Warren Nighan, SVP of Quality and Regulatory at AngioDynamics (ANGO), sold 23,370 shares for approximately $344,006. This transaction occurred on July 30, 2026, and leaves him with 64,745 shares. While the stock is deemed "Significantly Overvalued" by GuruFocus's GF Value model, institutional investors (gurus) …

Baxter International (BAX) Stock Cools As Margin Pressure Tempers Guidance Lift

Baxter International's stock slipped 2% despite beating Q2 revenue and adjusted EPS expectations and raising full-year guidance. While the company showed progress in its turnaround with organic revenue growth and improved free cash flow, concerns remain about compressed margins and execution risks, including ongoing …

Merit Medical Systems, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:MMSI) 2026-07-31

Merit Medical Systems, Inc. (MMSI) released its Q2 2026 earnings call presentation, reporting an EPS of $1.19, which beat estimates by $0.23. The company also reported revenues of $418.84 million, a 9.51% year-over-year increase, beating estimates by $13.50 million. This slide deck accompanies their …

Solventum Corporation Revenue Breakdown – NYSE:SOLV

Form 4 Intuitive Surgical Inc For: 31 July By Investing.com

This article from Investing.com reports on a Form 4 filing for Intuitive Surgical Inc. dated July 31. The brief mention indicates an SEC filing related to insider transactions for the company. The article itself is very short and primarily serves as a placeholder for …

Form 4 AngioDynamics Inc For: 31 July By Investing.com

This article reports on a Form 4 filing for AngioDynamics Inc. for July 31st. It provides various financial market data, including indices, commodities, bonds, and shares, along with trending stocks and investment strategy suggestions. The core content is the announcement of the Form 4 …

Angiodynamics SVP Warren Nighan Jr sells $344,006 in stock

Warren Nighan Jr., Senior Vice President at AngioDynamics Inc., sold 23,370 shares of company stock for a total of $344,006. This transaction occurred as the stock trades near its 52-week high after a 67% gain, with InvestingPro analysis suggesting it is overvalued. Despite the …

Clear Channel Outdoor stock hits 52-week high at 2.44 USD

Clear Channel Outdoor Holdings Inc. stock reached a new 52-week high of $2.44, representing a 137.25% increase over the past year. This performance reflects strong investor confidence, though the stock is currently considered overvalued. The company's strategic initiatives and operational improvements have likely contributed …

Embecta Corp. (NASDAQ: EMBC) outlines Owen Mumford deal terms and pro forma results

Embecta Corp. has outlined the detailed terms and pro forma financial results of its acquisition of Owen Mumford Holdings Limited, which was completed on May 15, 2026. The deal involved an upfront cash payment of £126.0 million ($166.1 million) and potential earn-out payments of …

Merit Medical Systems, Inc. Stock 12‑Month Price Target Raised to $99.82, Implies 20% Upside

Merit Medical Systems, Inc.'s average 12-month price target has been increased to $99.82 from $90.09, based on estimates from 11 analysts. This updated target suggests a potential upside of approximately 20% from the July 30 closing price. The consensus rating for MMSI stock remains …

Kestra Medical Technologies (KMTS) insider files to sell 8,759 shares under Rule 144

Kestra Medical Technologies insider Timothy Moran has filed a notice to sell up to 8,759 shares of common stock under Rule 144, with an aggregate market value of $198,000.29 as of July 31, 2026. These shares are from vested performance share unit awards. The …

Kestra Medical Technologies (KMTS) insider plans $196K Rule 144 stock sale

An insider at Kestra Medical Technologies (KMTS), Alfred J Ford, plans to sell 8,681 shares of common stock under Rule 144, valued at approximately $196,284.58. The sale, expected on July 31, 2026, involves shares from performance share unit awards that vested on July 17, …

Earnings Flash (ATR) AptarGroup, Inc. Posts Q2 Adjusted EPS $1.42 per Share, Vs. FactSet Est of $1.35

AptarGroup, Inc. (ATR) reported its Q2 adjusted EPS of $1.42 per share, surpassing FactSet's estimate of $1.35 per share. This indicates a stronger-than-expected financial performance for the quarter.

Form 4 Anteris Technologies Global Corp. For: 31 July By Investing.com

This article announces the filing of Form 4 for Anteris Technologies Global Corp. for the 31st of July. Form 4 is a U.S. Securities and Exchange Commission filing used to disclose changes in beneficial ownership of a company's securities by insiders. The brief news …

Zentek Ltd (ZTEK) Institutional Confidence

This article from TradingKey focuses on the institutional confidence in Zentek Ltd (ZTEK). It highlights key shareholder activity, including the number of shares held by various institutions and individuals like Gregory Fenton, Scotia Capital Inc., and Colin Stuart Van der Kuur, along with their …